Vincent Deramecourt

Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia.

Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.

Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease.

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.

Bilateral temporal glioma presenting as a paraneoplastic limbic encephalitis with pure cognitive impairment.

Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.

Tau as a biomarker of neurodegenerative diseases.

CHMP2B mutations are rare in French families with frontotemporal lobar degeneration.

What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?

Prevalence of small cerebral bleeds in patients with a neurodegenerative dementia: a neuropathological study.

[Cognitive impairment and chronic kidney disease: which links?].

[Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?].

An 88-year old woman with long-lasting parkinsonism.

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.

Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias.

Contribution of single photon emission computed tomography to the differential diagnosis of dementia in a memory clinic.

Microbleeds in postmortem brains of patients with Alzheimer disease: a T2*-weighted gradient-echo 7.0 T magnetic resonance imaging study.

Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S.

Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers.

Methionine synthase deficiency: a rare cause of adult-onset leukoencephalopathy.

Reasons that prevent the inclusion of Alzheimer's disease patients in clinical trials.

A new decision tree combining Abeta 1-42 and p-Tau levels in Alzheimer's diagnosis.

Prevalence of cerebrovascular lesions in patients with Lewy body dementia: a neuropathological study.

C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.

Quantitative vascular pathology and phenotyping familial and sporadic cerebral small vessel diseases.

[From Pick's disease to frontotemporal dementia].

Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain.

Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R.

Unusual features of Creutzfeldt-Jakob disease followed-up in a memory clinic.

Neuron volumes in hippocampal subfields in delayed poststroke and aging-related dementias.